Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3824 | 1826 | 34.7 | 62% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
754 | 11793 | MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ENDOMETRIAL SAFETY | Author keyword | 15 | 62% | 1% | 16 |
2 | TRIMEGESTONE | Author keyword | 15 | 59% | 1% | 17 |
3 | CAS 53 16 7 | Author keyword | 15 | 88% | 0% | 7 |
4 | CAS 50 28 2 | Author keyword | 12 | 75% | 0% | 9 |
5 | ESTROGEN REPLACEMENT THERAPY | Author keyword | 12 | 16% | 4% | 70 |
6 | ESTRADIOL GEL | Author keyword | 9 | 83% | 0% | 5 |
7 | MENORESTR | Author keyword | 8 | 100% | 0% | 5 |
8 | OESCLIM R | Author keyword | 8 | 100% | 0% | 5 |
9 | BLEEDING PATTERN | Author keyword | 7 | 35% | 1% | 17 |
10 | TRANSDERMAL ESTRADIOL | Author keyword | 7 | 32% | 1% | 19 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENDOMETRIAL SAFETY | 15 | 62% | 1% | 16 | Search ENDOMETRIAL+SAFETY | Search ENDOMETRIAL+SAFETY |
2 | TRIMEGESTONE | 15 | 59% | 1% | 17 | Search TRIMEGESTONE | Search TRIMEGESTONE |
3 | CAS 53 16 7 | 15 | 88% | 0% | 7 | Search CAS+53+16+7 | Search CAS+53+16+7 |
4 | CAS 50 28 2 | 12 | 75% | 0% | 9 | Search CAS+50+28+2 | Search CAS+50+28+2 |
5 | ESTROGEN REPLACEMENT THERAPY | 12 | 16% | 4% | 70 | Search ESTROGEN+REPLACEMENT+THERAPY | Search ESTROGEN+REPLACEMENT+THERAPY |
6 | ESTRADIOL GEL | 9 | 83% | 0% | 5 | Search ESTRADIOL+GEL | Search ESTRADIOL+GEL |
7 | MENORESTR | 8 | 100% | 0% | 5 | Search MENORESTR | Search MENORESTR |
8 | OESCLIM R | 8 | 100% | 0% | 5 | Search OESCLIM+R | Search OESCLIM+R |
9 | BLEEDING PATTERN | 7 | 35% | 1% | 17 | Search BLEEDING+PATTERN | Search BLEEDING+PATTERN |
10 | TRANSDERMAL ESTRADIOL | 7 | 32% | 1% | 19 | Search TRANSDERMAL+ESTRADIOL | Search TRANSDERMAL+ESTRADIOL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POST MENOPAUSAL WOMEN | 35 | 21% | 8% | 147 |
2 | PROGESTOGEN THERAPY | 32 | 63% | 2% | 32 |
3 | ENDOMETRIAL HISTOLOGY | 27 | 83% | 1% | 15 |
4 | TRANSDERMAL ESTRADIOL | 26 | 27% | 5% | 83 |
5 | CONJUGATED ESTROGENS | 24 | 30% | 4% | 67 |
6 | INTRANASAL 17 BETA ESTRADIOL | 17 | 70% | 1% | 14 |
7 | POSTMENOPAUSAL BONE LOSS | 14 | 21% | 3% | 58 |
8 | TTSR 50 | 14 | 100% | 0% | 7 |
9 | PROGESTOGENS | 13 | 21% | 3% | 56 |
10 | GESTAGEN | 13 | 80% | 0% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
HORMONE REPLACEMENT THERAPY AND ENDOMETRIAL CANCER RISK - A METAANALYSIS | 1995 | 573 | 46 | 61% |
Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women | 2002 | 149 | 76 | 49% |
Hormone replacement therapy and prevention of nonvertebral fractures - A meta-analysis of randomized trials | 2001 | 263 | 33 | 48% |
Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000 | 2001 | 205 | 242 | 49% |
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia | 2009 | 19 | 114 | 77% |
Pharmacology of estrogens and progestogens: influence of different routes of administration | 2005 | 114 | 279 | 30% |
COMBINED CONTINUOUS HORMONE REPLACEMENT THERAPY - A CRITICAL-REVIEW | 1995 | 99 | 56 | 79% |
Low-dose estrogen therapy for menopausal women: A review of efficacy and safety | 2003 | 17 | 45 | 89% |
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia | 2012 | 3 | 124 | 75% |
The WHI: the effect of hormone replacement therapy on fracture prevention | 2012 | 9 | 14 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MENOPAUSE PMS | 2 | 67% | 0.1% | 2 |
2 | GYNAECOL GRP | 2 | 36% | 0.2% | 4 |
3 | ABT GYNAKOL ENDOKRINOL | 1 | 38% | 0.2% | 3 |
4 | ESP GYNECOL ONCOL | 1 | 100% | 0.1% | 2 |
5 | WERPUNKT ENDOKRINOL MENOPAUSE | 1 | 40% | 0.1% | 2 |
6 | BERNARDINO RIVADAVIA HOSP | 1 | 50% | 0.1% | 1 |
7 | C ROYAL MELBOURNE HOSP | 1 | 50% | 0.1% | 1 |
8 | CENTENARIO HOSP | 1 | 50% | 0.1% | 1 |
9 | CLIMACTER CLIN | 1 | 50% | 0.1% | 1 |
10 | CLIN CONCEPT REPROD MED | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000251208 | WOMENS HEALTH INITIATIVE//INTERDISCIPLINARY GRP OSTEOPOROSIS//WHI STUDY |
2 | 0.0000198634 | TIBOLONE//TIBOLONE METABOLITES//LIVIAL |
3 | 0.0000174233 | HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS |
4 | 0.0000159627 | DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST |
5 | 0.0000138505 | VAGINAL ATROPHY//UROGENITAL ATROPHY//VULVOVAGINAL ATROPHY |
6 | 0.0000117826 | DIETARY CA RESTRICTION//ZURICH OSTEOPOROSIS GRP//1 ALPHA HYDROXYVITAMIN D 3 |
7 | 0.0000114504 | TRANSDERMAL THERAPEUTIC SYSTEMS//TRANSDERMAL THERAPEUTIC SYSTEM//AGROMEDICINE |
8 | 0.0000085557 | NUTR HORMONES UNIT//ENDOMETRIAL CANCER RISK//ENDOMETRIAL NEOPLASMS |
9 | 0.0000085517 | RING B UNSATURATED ESTROGENS//17 BETA DIHYDROEQUILIN//EQUILIN |
10 | 0.0000078202 | HOT FLASHES//VASOMOTOR SYMPTOMS//HOT FLUSHES |